$SG

Sweetgreen Stock Slides Friday: What's Driving the Action? - Sweetgreen (NYSE:SG)

Sweetgreen (NYSE:SG) shares fell about 9.7% in premarket after Q2 results missed expectations. The company reported a net loss of 22 cents per share versus a 14 cent loss estimate, with revenue of $192.66 million below $194.90 million. Same-store sales declined 6.2%, and restaurant profit margin fell to 13.1%. Sweetgreen cut its 2026 outlook, citing weaker demand after a cyclosporiasis outbreak; TD Cowen lowered its price target to $5 from $8.

Original reporting
Published Aug 7, 2026, 1:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 5:10 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SG
Bearish
high confidence
Mentioned
$SG
Relevance
9/10
alphai data visualization · based on benzinga.com
Decision brief

The 30-second read

$SGBearishHigh
01

Why it matters

Investors are likely repricing SG’s forward demand and profitability given the combination of traffic decline, mix headwinds from higher promotions, and margin compression, reinforced by a revised full-year same-store sales range of -7% to -8%.

02

Market read

A guidance reset and operational deterioration provide a fresh, company-specific catalyst that can drive continued volatility in SG and fast-casual prepared-food sentiment.

03

What to watch

The article attributes the outlook cut to reduced demand after a cyclosporiasis outbreak; traders may want to monitor whether the impact is transient versus structural, and whether promotional intensity normalizes to support mix and margins.

Relevance 9/10Novelty 8/10Timing: premarket Friday after Q2 results and outlook revision

Background

The piece frames SG’s weakness around a Q2 earnings miss, deteriorating same-store sales, and a guidance reduction for 2026 tied to a multistate cyclosporiasis outbreak.

Company-level read

Ticker impact

$SGBearishHigh confidence
Context

Sweetgreen reported Q2 net loss of 22 cents per share and revenue of $192.66M, both missing expectations, alongside same-store sales down 6.2%.

Expected impact

Bearish near-term bias, with elevated downside risk until investors digest the revised same-store sales outlook and margin trajectory.

Evidence & confidence

The article provides concrete Q2 results (EPS, revenue), operational KPIs (traffic, product mix, restaurant margin), and a specific full-year outlook revision tied to demand disruption from a cyclosporiasis outbreak.

Market effects

Signals heightened risk for fast-casual prepared-food operators when food-safety incidents disrupt traffic and mix, potentially pressuring sector multiples.

No specific regional impact is described beyond the multistate outbreak context.

Limited global relevance; this is primarily a US-listed company earnings and guidance reset.

Counterpoint

Management says guest response to new wrap offerings and restaurant execution are improving, which could partially offset the near-term demand shock if trends stabilize.

Key entities

  • Sweetgreen

    Subject of the article, with Q2 results and a revised 2026 outlook driving the stock’s premarket decline.

  • TD Cowen

    Trimmed its price target on SG from $8 to $5 after the announcement.

Related articles

$SGHighAI 9/10

Sweetgreen (SG) Q2 2026 Earnings Call Transcript

Sweetgreen (SG) reported Q2 2026 revenue of $192.7M, up 4% YoY, driven by 36 net new restaurant openings. Same-store sales fell 6.2%. Restaurant-level margin was 13.1% and adjusted EBITDA was a $0.2M loss. FY2026 guidance was revised for cyclospora impacts, with comparable sales expected to decline 7% to 8% and restaurant margin 10.5% to 11.0%.

$SGHighAI 8/10

Sweetgreen Says Wraps Are a Hit With Diners, But Cyclospora Scare Clouds Outlook — BigGo Finance

Sweetgreen Inc. (NYSE:SG) said its lower-priced wraps are driving loyalty and transactions, with CEO Jonathan Neman citing about a 20% incidence rate since the national launch and a 30-day return rate above the Harvest Bowl. Cyclospora-related negative headlines in mid-July led the company to cut full-year 2026 guidance. Q2 revenue was $192.7M (+4% YoY), but comparable sales fell 6.2% and restaurant margin dropped to 13.1%.

$SGHighAI 8/10

After a Wraps Win, Sweetgreen Faces a Fresh Setback

Sweetgreen introduced lower-priced wraps after a weak Q1 to improve value perception and drive repeat visits. Wraps reached about a 20% incidence rate and improved retention, but same-store sales fell 6.2% in Q2. Revenue rose ~4% to $192.7M. A cyclospora-related demand hit led to a lowered full-year outlook and guidance.

$SGMed

Parasite Outbreak Fears Crush Restaurant Sales Weeks After RFK Jr. Said It Was “Under Control”

On July 21, HHS Secretary Robert F. Kennedy Jr. said the multistate cyclosporiasis outbreak tied to iceberg lettuce was “under control.” By Aug. 5, the CDC reported 6,358 illnesses in 15 states, 278+ hospitalizations, and two deaths. The FDA linked the recall to Taylor Farms, and restaurant chains including Sweetgreen (SG) and Salad and Go filed for Chapter 11, citing outbreak-related demand impacts.

$SGHighAI 9/10

Sweetgreen Q2 Earnings Call Highlights

Sweetgreen (NYSE:SG) reported Q2 comparable transaction declines narrowing from -11.2% in Q1 to about -3% in April-May and near flat in June. Restaurant-level profit was $25.2M (13.1% margin) and adjusted EBITDA was a $0.2M loss. Wraps drove frequency but lower check weighed mix. Sweetgreen cut 2026 outlook for disruption, expecting comps -8% to -7% and adjusted EBITDA loss of $27M to $23M.

$SGHighAI 9/10

Sweetgreen Shares Slide After Weak Second-Quarter Results and Lower Outlook

Sweetgreen (NYSE:SG) shares fell about 15% premarket after it reported Q2 2026 results that missed expectations. Revenue rose 3.8% to $192.7M, but GAAP loss widened to $0.22 per share. Comparable sales fell 6.2% and restaurant margin dropped to 13.1% from 18.9%. Sweetgreen cut full-year EBITDA guidance to about -$25M at midpoint, citing a cyclospora outbreak.